Evidence map›Paper›PMID 42002974›Full record

ArticleJournal of the American Chemical Society2026

OptoChaperone─A Biohybrid Tool for Regulating Protein Condensates in Cells and In Vitro.

Do Thanh Tuan, Motonori Matsusaki, Honoka Ota, Soichiro Kawagoe, Hettimudalige Dilini Nisansala, Munehiro Kumashiro, Noriyoshi Isozumi, Hiroyuki Kumeta, Yohei Kono, Takeshi Shimi and 4 more

Abstract read
In one paragraph

Article in Journal of the American Chemical Society, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Do Thanh TuanDepartment of Physiology, Hanoi Medical University, Hanoi 100000, Vietnam.
Motonori MatsusakiInstitute of Advanced Medical Sciences, Tokushima University, Tokushima, Tokushima 770-8503, Japan.ORCID 0000-0002-7296-033X
Honoka OtaGraduate School of Chemical Sciences and Engineering, Hokkaido University, Sapporo, Hokkaido 060-8628, Japan.
Soichiro KawagoeInstitute of Advanced Medical Sciences, Tokushima University, Tokushima, Tokushima 770-8503, Japan.ORCID 0000-0002-7158-4504
Hettimudalige Dilini NisansalaGraduate School of Frontier Science Initiative, Division of Nano Life Science, Kanazawa University, Kakuma-machi, Kanazawa 920-1192, Japan.
Munehiro KumashiroInstitute of Advanced Medical Sciences, Tokushima University, Tokushima, Tokushima 770-8503, Japan.
Noriyoshi IsozumiDepartment of Future Basic Medicine, Nara Medical University, Kashihara, Nara 634-8521, Japan.
Hiroyuki KumetaFaculty of Advanced Life Science, Hokkaido University, Sapporo, Hokkaido 001-0021, Japan.ORCID 0000-0003-3713-2122
Yohei KonoNano Life Science Institute (WPI-NanoLSI), Kanazawa University, Kakuma-machi, Kanazawa 920-1192, Japan.ORCID 0000-0001-8264-9417
Takeshi ShimiNano Life Science Institute (WPI-NanoLSI), Kanazawa University, Kakuma-machi, Kanazawa 920-1192, Japan.
Koichiro IshimoriGraduate School of Chemical Sciences and Engineering, Hokkaido University, Sapporo, Hokkaido 060-8628, Japan.ORCID 0000-0002-5868-0462
Eiichiro MoriDepartment of Future Basic Medicine, Nara Medical University, Kashihara, Nara 634-8521, Japan.
Satoshi AraiNano Life Science Institute (WPI-NanoLSI), Kanazawa University, Kakuma-machi, Kanazawa 920-1192, Japan.ORCID 0000-0003-4807-8248
Tomohide SaioGraduate School of Medicine, Tokushima University, Tokushima, Tokushima 770-8503, Japan.ORCID 0000-0003-3639-7399

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Protein condensates formed via liquid-liquid phase separation (LLPS) are increasingly recognized as key players in diverse cellular processes, including those associated with disease. Despite extensive efforts to characterize their formation and function, tools that enable precise, reversible, and spatiotemporal control of LLPS remain limited. Here, we report OptoChaperone, a light-activatable molecular system designed to manipulate protein condensates both in vitro and in living cells. This biohybrid system leverages photoresponsive switching to control chaperone activity: blue light triggers the suppressive function, leading to the dissolution of protein condensates, whereas UV light deactivates the system, allowing condensate formation. We demonstrate the efficacy of OptoChaperone in regulating several disease-related protein condensates, such as fused in sarcoma, TAR DNA-binding protein 43, and heat shock factor 1. Importantly, the system exhibits reversible and robust control over droplet dynamics without requiring chemical additives or genetic modifications of the client proteins. Given the reversibility and efficiency of OptoChaperone in the manipulation of protein condensates, this tool offers a powerful platform for dissecting the roles of protein condensation in cellular physiology and pathology. This strategy also holds potential for broader applications in synthetic biology, biomolecular engineering, and therapeutic modulation of aberrant phase separation.

Indexed as

Biomolecular CondensatesMolecular ChaperonesBlue LightHumansPhase SeparationUltraviolet RaysMolecular Chaperones

Identifiers

PMID42002974
PMCPMC13133789

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.